On August 28, 2026, Creative Medical Technology Holdings, Inc. stockholders approved an amendment to increase authorized common shares from 25 million to 100 million and the full exercise of investor warrants for 5,580,680 shares. The share increase proposal passed with 2,488,537 votes in favor against 595,527, while warrant approval received 678,541 votes for and 344,460 against. Creative Medical Technology Holdings operates in the medical technology sector, focusing on minimally invasive treatments for chronic pain.

Creative Medical Technology Holdings, Inc. entered into inducement letters with warrant holders to reduce the exercise price of 2,790,340 existing warrants from $2.86 to $1.60 per share, generating approximately $4.5 million in gross proceeds. In exchange, the company issued 5,580,680 new inducement warrants at an exercise price of $1.60 per share. The company plans to use the net proceeds for working capital and general corporate purposes. Creative Medical Technology is a medical technology company providing medical devices and services.